Regeneron Pharmaceuticals
REGN
#327
Rank
โ‚น7.212 T
Marketcap
โ‚น70,054
Share price
-1.19%
Change (1 day)
34.86%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2026 (TTM): โ‚น473.06 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are โ‚น15.53 Billion. In 2025 the company made an earning of โ‚น504.39 Billion, an increase over its 2024 earnings that were of โ‚น460.92 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น473.06 B-6.21%
2025 โ‚น504.39 B9.43%
2024 โ‚น460.92 B13.83%
2023 โ‚น404.93 B-13.57%
2022 โ‚น468.53 B-47.9%
2021 โ‚น899.28 B144.75%
2020 โ‚น367.43 B56.86%
2019 โ‚น234.23 B-4.87%
2018 โ‚น246.24 B22.86%
2017 โ‚น200.43 B56.3%
2016 โ‚น128.23 B8.55%
2015 โ‚น118.13 B54.53%
2014 โ‚น76.44 B11.14%
2013 โ‚น68.78 B72.13%
2012 โ‚น39.96 B-285.93%
2011 -โ‚น21.5 Billion121.73%
2010 -โ‚น9.7 Billion37.18%
2009 -โ‚น7.07 Billion-14.6%
2008 -โ‚น8.28 Billion-25.02%
2007 -โ‚น11.04 Billion6.32%
2006 -โ‚น10.39 Billion-186.52%
2005 โ‚น11.99 B2103.7%
2004 โ‚น0.54 B-105.66%
2003 -โ‚น9.63 Billion-18.18%
2002 -โ‚น11.77 Billion42.33%
2001 -โ‚น8.27 Billion129.35%
2000 -โ‚น3.61 Billion51.87%
1999 -โ‚น2.38 Billion92.19%
1998 -โ‚น1.24 Billion66.23%
1997 -โ‚น0.75 Billion-55.49%
1996 -โ‚น1.67 Billion103.53%
1995 -โ‚น0.82 Billion-70.89%
1994 -โ‚น2.82 Billion-26.08%
1993 -โ‚น3.81 Billion114.67%
1992 -โ‚น1.78 Billion196.77%
1991 -โ‚น0.6 Billion87.88%
1990 -โ‚น0.32 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.527 T 407.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.496 T 200.46%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
โ‚น991.97 B 99.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น690.46 B 38.60%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
โ‚น97.52 B-80.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น108.44 B-78.23%๐Ÿ‡บ๐Ÿ‡ธ USA